V

Varian

Tech-enabled radiation oncology hardware and software

Zone General Manager

Full-TimeUpdated on 10/23/2026
$280k - $385k+ Commission eligibility
Expert
Bachelor's, Master's, MBA
Remote in USA+3 moreMore locations: Nashville, TN, USA | Columbia, SC, USA | Atlanta, GA, USA
RemoteRemote role; travel within the zone is 70%.
Sales & Account ManagementField Sales
Company Historically Provides H1B Sponsorship

About the job

Requirements
  • At least 15 years of sales leadership experience in medical technology or diagnostic imaging, with a strong track record of driving growth.
  • A bachelor's degree is required.
  • Demonstrated ability to lead across a matrix organization and empower managers to achieve business outcomes.
  • Strong intra-organizational collaboration skills and the ability to influence and negotiate at senior levels.
  • A proven track record in leadership, targeting, and closing strategic accounts within the zone.
  • Willingness to travel within the zone 70% of the time.
Responsibilities
  • Develop the zone business strategy in line with the overall Siemens Healthineers North American strategy and drive an integrated solutions strategy for Imaging, Advanced Therapies, and Services across customer segments.
  • Lead and develop a high-performing sales organization in the Southeast Zone, accountable for revenue, market share, profitability, and company goals, including employee and customer satisfaction and financial metrics.
  • Manage regional account teams and set growth targets for Regional Vice Presidents and Area Vice Presidents.
  • Build and maintain relationships with healthcare executives, provider networks, distributors, and non-traditional channels to expand market reach.
  • Oversee zone sales leadership to ensure consistent performance, develop talent, and plan for succession; lead through proactive communication and change management.
  • Develop and coach direct reports and the zone team to foster a high-performance culture.
  • Build credibility with customers and develop long-lasting executive-level customer relationships, with significant time spent at customer sites.
  • Lead strategic partnerships with luminary customers in Integrated Delivery Networks, academic and research institutions, and Healthineers Strategic Alliances.
  • Collaborate with business lines and regional functions, including Services, Project Management, Solution Implementations, and Finance, to achieve strategic goals.
  • Improve business processes, enhance customer satisfaction, ensure accurate forecasting and transparency, and manage sales tools across the zone.
  • Develop strategies to grow Siemens Healthineers solutions, including Population Health, Managed Equipment Services, and Integrated Service Management contracts.
  • Cultivate a diverse, inclusive, high-performance culture within the zone team and beyond, modeling integrity, transparency, and values-based leadership.
Desired Qualifications
  • An MBA or advanced degree is preferred.
  • Deep knowledge of imaging or related healthcare technologies, an understanding of industry macro trends, and comprehensive knowledge of the market and customer landscape are preferred.

About the company

Varian, part of Siemens Healthineers, focuses on oncology by providing integrated radiation oncology solutions that combine software, hardware, patient data, and care teams. Its offerings include treatment-planning software, radiation therapy machines, and data-management systems that work together to enable precise cancer treatments. The company differentiates itself through an integrated platform approach and services like Oncology-as-a-Service (OaaS), which lets healthcare providers adopt advanced radiation oncology with ongoing service support rather than large upfront investments. Varian serves healthcare providers such as hospitals and cancer centers, helping them deliver coordinated care and improve patient outcomes. Its goal is to reduce the fear of cancer by using data and technology to support clinicians in delivering effective treatments.

Company Size

5,001-10,000

Company Stage

IPO

Headquarters

Palo Alto, California

Founded

1948

Get referred to Varian

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • ARPA-H awarded Varian up to $60 million in April 2026 for FLASH-RT.
  • FDA cleared TrueBeam for osteoarthritis in March 2026, opening a non-cancer market.
  • Telix collaboration and 2026 AI approvals expand Varian's clinical and software pipeline.

What critics are saying

  • RaySearch enabled online adaptive TrueBeam workflows in Belgium in May 2026, eroding software differentiation.
  • Elekta still attacks Varian's lead in adaptive radiotherapy and premium MR-guided care.
  • If FLASH and non-oncology bets fail by 2028, Varian becomes a commoditized linear-accelerator vendor.

What makes Varian unique

  • Siemens Healthineers gives Varian imaging, radiotherapy, and capital-sales integration globally.
  • Varian's 2026 CE-marked Eclipse AI contouring deepens workflow lock-in across planning.
  • TrueBeam, Halcyon, and Ethos create an installed-base moat hospitals rarely replace.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Flexible Work Hours
  • Remote Work Options
  • Paid Vacation
  • Paid Holidays
  • Health Insurance
  • Dental Insurance
  • Vision Insurance
  • Wellness Program
  • 401(k) Retirement Plan

Growth & Insights and Company News

6 month growth

2%

1 year growth

3%

2 year growth

3%
Varex Imaging Corporation
Sep 14th, 2026
About Us | Varex Imaging Corporation

We strive to help customers become world-class system suppliers by strengthening their competitiveness and enabling them to bring products to market faster

MEDQOR
Apr 30th, 2026
Siemens Healthineers secures $83M to develop photon Flash radiotherapy for cancer treatment

Siemens Healthineers has received up to $60 million from the US Advanced Research Projects Agency for Health to develop photon Flash radiotherapy, with the company contributing an additional $23 million, totalling $83 million over five years. Flash photon therapy delivers radiotherapy more than 100 times faster than current technologies, aiming to reduce side effects and improve healthy tissue sparing. Unlike proton and electron beam platforms, which face scalability challenges, photon beams are the standard of care for over 50% of cancer patients. The project will build on existing C-arm linear accelerators to enable broader clinical access. Siemens Healthineers aims to transition ultra-high dose rate radiotherapy from experimental treatment into global standard of care within the five-year timeframe.

Business Wire
Mar 19th, 2026
Varian TrueBeam gets FDA clearance for low-dose radiotherapy to treat osteoarthritis

Siemens Healthineers has received FDA 510(k) clearance for its Varian TrueBeam radiotherapy systems to treat medically refractory osteoarthritis in adults using low-dose radiation therapy. This marks the first expansion of Varian's radiotherapy platform beyond cancer care into chronic musculoskeletal conditions. Osteoarthritis affects over 33 million adults in the US and approximately 600 million globally. The clearance covers TrueBeam, TrueBeam STx, VitalBeam and Edge systems, offering patients with persistent pain a non-invasive outpatient treatment option that targets inflammation, reduces pain and improves joint function. The approval builds on Varian's previous regulatory clearances for non-oncological indications, including radiosurgery treatment for medically refractory essential tremor. The TrueBeam platform combines high-resolution imaging with precise dose control whilst maintaining streamlined clinical workflows.

AuntMinnieEurope.com
Dec 10th, 2025
Telix and Varian enter research collaboration

Telix and Varian enter research collaboration. Telix Pharmaceuticals and Siemens Healthineers' company Varian have agreed to develop novel clinical applications that combine Telix's theranostics products and Varian's external beam radiation therapy (EBRT) technology. The first area of focus will be in identifying opportunities to use Telix's prostate cancer PET imaging agents in selecting patients for EBRT, developing personalized treatment plans (particularly in the context of Varian's Ethos adaptive radiotherapy system), and monitoring responses to treatment, Telix said. The agreement supports both company-sponsored and investigator-led clinical studies. Varian is a key player in EBRT and working with the company will allow Telix to explore how theranostics can be used more effectively by radiation oncologists to enhance patient selection and deliver targeted treatment, Telix noted. I agree to receive marketing related digital communications about products, services, events and offers that may be relevant to my given user preferences and behavior. I agree to share my information with the sponsor. I have read and agree to the privacy policy & terms of service and wish to opt-in.

AuntMinnie.com
Mar 28th, 2025
Varian, Embolx sign image-guided microcatheter agreement

Siemens Healthineers company Varian has entered into a sales and marketing agreement with Embolx for its Sniper Balloon Occlusion Microcatheter.